iCAD (ICAD) Competitors $1.83 +0.06 (+3.39%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ICAD vs. SGHT, LAKE, BWAY, PDEX, NVRO, SRTS, ZJYL, TLSI, TELA, and GUTSShould you be buying iCAD stock or one of its competitors? The main competitors of iCAD include Sight Sciences (SGHT), Lakeland Industries (LAKE), BrainsWay (BWAY), Pro-Dex (PDEX), Nevro (NVRO), Sensus Healthcare (SRTS), Jin Medical International (ZJYL), TriSalus Life Sciences (TLSI), TELA Bio (TELA), and Fractyl Health (GUTS). These companies are all part of the "medical equipment" industry. iCAD vs. Sight Sciences Lakeland Industries BrainsWay Pro-Dex Nevro Sensus Healthcare Jin Medical International TriSalus Life Sciences TELA Bio Fractyl Health iCAD (NASDAQ:ICAD) and Sight Sciences (NASDAQ:SGHT) are both small-cap computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability, dividends and community ranking. Which has more volatility & risk, ICAD or SGHT? iCAD has a beta of 1.43, indicating that its share price is 43% more volatile than the S&P 500. Comparatively, Sight Sciences has a beta of 2.58, indicating that its share price is 158% more volatile than the S&P 500. Does the media prefer ICAD or SGHT? In the previous week, iCAD and iCAD both had 1 articles in the media. iCAD's average media sentiment score of 0.75 beat Sight Sciences' score of 0.00 indicating that iCAD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iCAD 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sight Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals believe in ICAD or SGHT? 24.6% of iCAD shares are held by institutional investors. Comparatively, 55.5% of Sight Sciences shares are held by institutional investors. 10.3% of iCAD shares are held by insiders. Comparatively, 28.9% of Sight Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is ICAD or SGHT more profitable? iCAD has a net margin of -17.81% compared to Sight Sciences' net margin of -63.30%. iCAD's return on equity of -15.65% beat Sight Sciences' return on equity.Company Net Margins Return on Equity Return on Assets iCAD-17.81% -15.65% -12.52% Sight Sciences -63.30%-47.28%-32.72% Does the MarketBeat Community favor ICAD or SGHT? iCAD received 211 more outperform votes than Sight Sciences when rated by MarketBeat users. Likewise, 62.13% of users gave iCAD an outperform vote while only 29.82% of users gave Sight Sciences an outperform vote. CompanyUnderperformOutperformiCADOutperform Votes22862.13% Underperform Votes13937.87% Sight SciencesOutperform Votes1729.82% Underperform Votes4070.18% Do analysts rate ICAD or SGHT? Sight Sciences has a consensus target price of $5.12, suggesting a potential upside of 43.42%. Given Sight Sciences' stronger consensus rating and higher probable upside, analysts clearly believe Sight Sciences is more favorable than iCAD.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iCAD 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sight Sciences 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17 Which has better earnings & valuation, ICAD or SGHT? iCAD has higher earnings, but lower revenue than Sight Sciences. iCAD is trading at a lower price-to-earnings ratio than Sight Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiCAD$18.94M2.56-$4.85M-$0.13-14.08Sight Sciences$79.54M2.28-$55.55M-$1.02-3.50 SummaryiCAD beats Sight Sciences on 9 of the 17 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get iCAD News Delivered to You Automatically Sign up to receive the latest news and ratings for ICAD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICAD vs. The Competition Export to ExcelMetriciCADSurgical & medical instruments IndustryComputer SectorNASDAQ ExchangeMarket Cap$48.57M$4.36B$24.26B$9.08BDividend YieldN/A41.45%2.71%4.18%P/E Ratio-14.0825.01270.7417.17Price / Sales2.5645.673,157.20115.67Price / CashN/A43.4633.6737.88Price / Book1.447.367.754.78Net Income-$4.85M$13.64M$661.21M$225.60M7 Day Performance-6.15%-2.76%0.44%-1.26%1 Month Performance18.45%0.38%9.01%4.37%1 Year Performance10.91%44.25%26.14%18.73% iCAD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICADiCAD0.2943 of 5 stars$1.83+3.4%N/A+10.9%$48.57M$18.94M-14.0867SGHTSight Sciences3.391 of 5 stars$3.70+3.4%$5.12+38.4%+7.2%$187.81M$81.06M-3.51210News CoverageGap UpLAKELakeland Industries4.5762 of 5 stars$23.53+3.7%$26.50+12.6%+28.5%$174.26M$151.82M-252.221,750Analyst ForecastAnalyst RevisionBWAYBrainsWay4.1415 of 5 stars$9.55+1.4%$13.17+37.9%+40.9%$159.28M$38.63M95.20120PDEXPro-Dex2.0625 of 5 stars$48.80-1.3%$52.00+6.6%+181.2%$159.09M$53.84M32.10140NVRONevro2.1418 of 5 stars$4.20+3.2%$8.05+91.7%-82.0%$157.37M$425.17M-2.231,215Analyst ForecastSRTSSensus Healthcare3.9859 of 5 stars$8.02-1.7%$12.50+55.9%+186.3%$131.45M$24.41M14.3240Positive NewsZJYLJin Medical InternationalN/A$0.79+2.1%N/A-99.0%$123.15M$19.82M0.00245Gap DownTLSITriSalus Life Sciences4.0096 of 5 stars$4.00+2.3%$12.08+202.1%-50.5%$121.97M$26.89M-1.57106Analyst ForecastInsider TradeNews CoverageGap UpTELATELA Bio2.9974 of 5 stars$2.82+1.8%$9.25+228.0%-49.8%$111.08M$58.45M-1.64120GUTSFractyl Health0.8814 of 5 stars$2.10+2.9%$22.00+947.6%N/A$101.01M$120,000.00-0.17102 Related Companies and Tools Related Companies Sight Sciences Alternatives Lakeland Industries Alternatives BrainsWay Alternatives Pro-Dex Alternatives Nevro Alternatives Sensus Healthcare Alternatives Jin Medical International Alternatives TriSalus Life Sciences Alternatives TELA Bio Alternatives Fractyl Health Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ICAD) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iCAD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iCAD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ICAD Stock Alerts